ArticleOncology letters2025

Respiratory microbiota diversity as a predictive biomarker for the efficacy of PD‑1 blockades in patients with advanced non‑small cell lung cancer: A retrospective exploratory study.

Liang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.